Amyris News and Activities

Amyris is a company listed under the stock ticker AMRS (US).

View the org chart displaying its 28 main executives

Most searched biographies at Amyris

• Kathy Fortmann, Chief Executive Officer
• Scott White, Director
• Ryan Panchadsaram, Director

Create your alert
to follow the executive moves at Amyris.

Amyris has 2,425 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Apnimed has filed its IPO. Its stock ticker will be APMD. (posted on July 13 2026).
• The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Amyris

• Press Release - SEPTEMBER 2, 2025 - Amyris
• Press Release - MAY 29 2025 - Amyris
• Press Release - May 7, 2024 - Amyris
• Newsroom | Amyris Biotechnology Company
• Press Releases | Amyris Investors
• Press Releases | Amyris Investors
• Press Releases | Amyris Investors
• Press Releases | Amyris Investors
• Press Releases | Amyris Investors
• Press Releases | Amyris Investors
• View more press releases Close

Social media about Amyris

• Amyris on Wikipedia, Google News & Yahoo Finance
• Amyris on LinkedIn, X (Twitter) & YouTube